[TYR0] GASTRIC INHIBITORY PEPTIDE (23-42), HUMAN

Request For Quotation
[TYR0] GASTRIC INHIBITORY PEPTIDE (23-42), HUMAN Suppliers list
Company Name: GL Biochem (Shanghai) Ltd  
Tel: 21-61263452 13641803416
Email: ymbetter@glbiochem.com
Company Name: Wuxi Zhongkun Biochemical Technology Co., Ltd.  
Tel: 0510-85629785 18013409632;
Email: sales@reading-chemicals.com
Company Name: Nanjing Peptide Biotech Ltd.  
Tel: 025-58361106-805 15951641583
Email: zhao.xu@njpeptide.com
Company Name: Hangzhou Peptidego Biotech Co.,Ltd.  
Tel: 0571-87213919 15967184799
Email: Eric@peptidego.com
Company Name: Nanjing Meihao Pharmaceutical Technology Co., Ltd.  
Tel: meitaochem@126.com
Email: meitaochem@126.com
[TYR0] GASTRIC INHIBITORY PEPTIDE (23-42), HUMAN Basic information
Product Name:[TYR0] GASTRIC INHIBITORY PEPTIDE (23-42), HUMAN
Synonyms:TYR-VAL-ASN-TRP-LEU-LEU-ALA-GLN-LYS-GLY-LYS-LYS-ASN-ASP-TRP-LYS-HIS-ASN-ILE-THR-GLN;[Tyr0] Gastric Inhibitory Peptide (23-42), human: [Tyr22] Gastric Inhibitory Peptide (22-42), human;TYR-VAL-ASN-TRP-LEU-LEU-ALA-GLN-LYS-GLY-LYS-LYS-ASN-ASP-TRP-LYS-HIS-ASN-ILE-THR-GLN: YVNWLLAQKGKKNDWKHNITQ;[Tyr22] Gastric Inhibitory Peptide (22-42), human;[TYR0] GASTRIC INHIBITORY PEPTIDE (23-42), HUMAN
CAS:121765-67-1
MF:C119H182N34O31
MW:2584.93
EINECS:
Product Categories:
Mol File:Mol File
[TYR0] GASTRIC INHIBITORY PEPTIDE (23-42), HUMAN Structure
[TYR0] GASTRIC INHIBITORY PEPTIDE (23-42), HUMAN Chemical Properties
Safety Information
MSDS Information
[TYR0] GASTRIC INHIBITORY PEPTIDE (23-42), HUMAN Usage And Synthesis
Uses[Tyr0] Gastric Inhibitory Peptide (23-42), human, a glucose-dependent insulinotropic polypeptide (GIP), is a weak inhibitor of gastric acid secretion that also stimulates insulin secretion. [Tyr0] Gastric Inhibitory Peptide (23-42), human can be used in diabetes, obesity research[1][2].
in vivo

GIPR-/- mice have higher blood glucose levels and impaired initial insulin response after oral glucose loading. In GIPR+/+ mice, a high-fat diet did not increase postprandial intake blood glucose levels, whereas it significantly increased in GIPR-/- mice[2].

References[1] LaPelusa A, et al. Biochemistry, Bombesin[M]//StatPearls [Internet]. StatPearls Publishing, 2021.
[2] K Miyawaki, et al. Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice. Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):14843-7. DOI:10.1073/pnas.96.26.14843
[TYR0] GASTRIC INHIBITORY PEPTIDE (23-42), HUMAN Preparation Products And Raw materials
Tag:[TYR0] GASTRIC INHIBITORY PEPTIDE (23-42), HUMAN(121765-67-1) Related Product Information
H-Tyr-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu-Ile-Arg-Ala-Thr-Ser-OH (Tyr0)-hypercalcemia of malignancy factor (1-34) (human, rat) H-Tyr-His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2 H-Tyr-Asp-Met-His-Asp-Phe-Phe-Val-Gly-Leu-Met-NH2 (TYR0)-C-TYPE NATRIURETIC PEPTIDE (32-53) (HUMAN, PORCINE, RAT) (TYR0)-KALIURETIC PEPTIDE (HUMAN) (TYR0)-FIBRINOPEPTIDE A (TYR0)-STRESSCOPIN-RELATED PEPTIDE (HUMAN) (TYR0)-UROCORTIN (RAT) (TYR0)-STRESSCOPIN (HUMAN)